12:00 AM
 | 
May 20, 2013
 |  BC Week In Review  |  Company News  |  Other News

Vivus endocrine/metabolic news

Vivus named Martin Carroll, formerly head of global strategy and development at Boehringer Ingelheim (Ingelheim, Germany), and Jorge Plutzky, director of The Vascular Disease Prevention Program, as independent directors. Vivus said both Carroll and Plutzky bring...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >